Journal article
Life and limb protection with dual anti-thrombotic pathway inhibition: COMPASS ushers in a new day in atherothrombotic risk reduction
Abstract
Inhibiting thrombosis is a cornerstone of vascular protection. Antiplatelet therapies, like aspirin and P2Y12 inhibitors, are used to prevent thrombosis and are widely endorsed in current clinical practice recommendations. Recent data suggest that "dual anti-thrombotic pathway inhibition" targeting platelets and coagulation may further reduce the residual atherosclerotic risk. This innovative thesis was tested in the COMPASS (Cardiovascular …
Authors
Verma S; Eikelboom JW; Al-Omran M; Choi R; Heffernan M; Teoh H; Bhatt DL
Journal
Med, Vol. 2, No. 3, pp. 233–242
Publisher
Elsevier
Publication Date
3 2021
DOI
10.1016/j.medj.2020.05.003
ISSN
2666-6359